Business Wire

Alcon Launches AcrySof ReSTOR Apodized Diffractive IOL; Revolutionary Apodized Diffractive Technology Provides Highest Level of Freedom from Glasses

FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...
Medscape

Monte Carlo Simulation of Expected Outcomes with the AcrySof

Background: To use a Monte Carlo simulation to predict postoperative results with the AcrySof ® Toric lens, evaluating the likelihood of over- or under-correction using various toric lens selection ...
Medscape

Rotational Stability of the AcrySof SA60TT Toric Intraocular Lenses: A Cohort Study

Background: To evaluate the rotational stability of the three types of AcrySof SA60TT toric intraocular lenses (Alcon, Switzerland) in cataract surgery after the first postoperative week. Methods: A ...
Healio

Thinking of piggybacking AcrySof IOLs? Don’t, surgeon says

SEATTLE — Unanticipated adverse effects have led a previously vocal advocate of piggyback AcrySof (Alcon Surgical, Fort Worth, U.S.A.) IOLs to urge surgeons to stop using the popular foldable lens in ...
Business Wire

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
Nasdaq

Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth ...
Healio

Studies examine AcrySof lenses in children

Evidence points to the decrease of posterior capsule opacification (PCO) in adults receiving the AcrySof (Alcon, Fort Worth, Texas) IOL, but pediatric surgeons are hoping to evaluate the same results ...
Yahoo Finance

Alcon receives FDA approval of new multifocal intraocular lens to treat cataract patients in the United States

Basel, Switzerland, April 16, 2015-Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® ...
MarketWatch

Alcon: FDA OKs AcrySof ReSTOR for cataract patients

SAN FRANCISCO (MarketWatch) -- Alcon Inc. said Wednesday after the closing bell that the Food and Drug Administration has granted approval for its intraocular lens, AcrySof ReSTOR, to be used by ...
Yahoo Finance

Alcon receives US FDA approval for new AcrySof® IQ ReSTOR® +2.5 Multifocal Toric IOL with ACTIVEFOCUS(TM) design for uncompromised distance vision and presbyopia correction

Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...
Houston Chronicle

(BW) AcrySof(R) IQ IOL Designated as a New Technology Intraocular Lens

FORT WORTH, Texas--(BUSINESS WIRE)--May 21, 2006--Alcon, Inc. (NYSE:ACL) announced today that the Centers for Medicare and Medicaid Services (CMS) recognized the AcrySof(R) IQ intraocular lens (IOL) ...
Nasdaq

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...